Trials / Completed
CompletedNCT01448525
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost ophthalmic solution 0.03% | One drop of bimatoprost ophthalmic solution 0.03% applied to the upper eyelid margin of both eyes once daily in the evenings for 16 weeks. |
| DRUG | bimatoprost vehicle solution | One drop of bimatoprost vehicle solution applied to the upper eyelid margin of both eyes once daily in the evenings for 16 weeks. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2011-10-07
- Last updated
- 2013-05-22
- Results posted
- 2013-05-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01448525. Inclusion in this directory is not an endorsement.